Table 3.
Symptomatic Hemorrhages Within 30 Days of EVD Insertion Among 250 Cases Enrolled in CLEAR III
| Patient # | Bleed | Timing | Anticoagulation |
|---|---|---|---|
| 1 | Catheter track (during dosing) | 5hrs. (after 3 doses) | No prophylactic anticoagulation |
| 2 | Catheter track (during dosing) | 31hrs. (after 2 doses) | No prophylactic anticoagulation |
| 3 | Catheter track (during dosing) | 48hrs | DVT prophylaxis (SQ Heparin) |
| 4 | New catheter placed for hydrocephalus after protocol; New ICH (new pontine hemorrhage) | Day 16 | Full anti-coagulation (site entered reason as ‘prevention of thrombosis’ |
| 5 | New catheter placed for hydrocephalus after protocol; (new massive IVH in left lateral ventricle) | Day 22 | On Enoxaparin (DVT prophylaxis) |
| 6 | Spontaneous new bleed; New ICH (different location than original stroke) | Day 16 | On Enoxaparin (DVT prophylaxis) |